Home
Parabilis Medicines

Parabilis Medicines Market Share Analysis for March 2026

Degrading androgen receptor (AR), a major driver of prostate cancers, by engaging outside the androgen-binding site.

Industry: N/A

Domainparabilismed.com

Year Founded2016

Employees51 - 200

Annual Revenue$5M - $10M

Parabilis Medicines

Parabilis Medicines (including company regionals)

parabilismed.com

See more website traffic and engagement information

Parabilis Medicines Revenue up to March 2026 is 5M - 10M

revenue generated by Parabilis Medicines top domains

Parabilis Medicines top domains revenue over 3 years

Revenue for Parabilis Medicines top domains

parabilismed.com5M - 10M

See more with Sales Intelligence

Total visits to Parabilis Medicines's top domains

Understand Parabilis Medicines market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

parabilismed.com25K

See more with Sales Intelligence

Avg. visit duration in Parabilis Medicines's top domains

Analyze Parabilis Medicines engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

parabilismed.com00:01:47

See more with Sales Intelligence

Avg. pageviews on Parabilis Medicines's top domains

See how Parabilis Medicines keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

parabilismed.com2.63

See more with Sales Intelligence

Parabilis Medicines top competitors by domain

Top similar sites in March 2026, ranked by their affinity

altoslabs.comCompany NameAltos LabsEmployees201 - 500HQUnited States, California, Redwood CityAnnual revenue--Total visits54KScience and Education > Biology

Top technologies used by Parabilis Medicines

These are the website technologies, by industry, used by Parabilis Medicines top domains

Payment & Currencies (10)

Cart Functionality

eCommerce (4)

OpenCart

Cryptocurrency (3)

Bitcoin Acceptance

Marketing (3)

Google Marketing Platform

More Technologies

9

See all

News & Signals from Parabilis Medicines

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsParabilis Med hired Helen Ho as Chief Business and Strategy Officer on Apr 14th '26.As Chief Business and Strategy Officer, Helen Ho, Ph.D. will lead Parabilis's corporate growth strategy, business development, and portfolio management to support advancement of the company's pipeline and continued expansion of its Helicon(TM) platform.

NewsParabilis Med hires Kotarakos as senior vice president of finance and business operations.Before joining Parabilis, Kotarakos served as senior vice president of finance and business operations at Codiak BioSciences and previously held senior finance positions at Seres Therapeutics.

NewsRA Cap invests into Parabilis Med $305M in Series F.Parabilis Medicines, $305M, precision medicines: Cambridge, Massachusetts-based Parabilis Medicines announced that it raised $305 million in a Series F financing co-led by RA Capital Management, Fidelity, and Janus Henderson Investors.